OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
Nicola Amodio, Lavinia Raimondi, Giada Juli, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 299

Showing 1-25 of 299 citing articles:

Long non-coding RNAs: From disease code to drug role
Yuanyuan Chen, Zhaojun Li, Xiaoguang Chen, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 2, pp. 340-354
Open Access | Times Cited: 378

Noncoding RNAs in cancer therapy resistance and targeted drug development
Wentao Wang, Cai Han, Yu-Meng Sun, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 233

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
Xinyi Zhang, Kai Xie, Honghua Zhou, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 205

MALAT1 Long Non-Coding RNA: Functional Implications
Gayatri Arun, Disha Aggarwal, David L. Spector
Non-Coding RNA (2020) Vol. 6, Iss. 2, pp. 22-22
Open Access | Times Cited: 203

lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer
Mu Xu, Xiaoxiang Chen, Lin Kang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 195

Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 192

lncRNAfunc: a knowledgebase of lncRNA function in human cancer
Mengyuan Yang, Huifen Lu, Jiajia Liu, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1295-D1306
Open Access | Times Cited: 108

FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Le Tao, Xingyu Mu, Haige Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 106

The genomic and transcriptional landscape of primary central nervous system lymphoma
Josefine Radke, Naveed Ishaque, Randi Koll, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 99

Targeting and engineering long non-coding RNAs for cancer therapy
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 68

MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting
Asif Ahmad Bhat, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154991-154991
Closed Access | Times Cited: 60

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
Vincenza Ylenia Cusenza, Annalisa Tameni, Antonino Neri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 44

Antisense Oligonucleotide-Conjugated Nanostructure-Targeting lncRNA MALAT1 Inhibits Cancer Metastasis
Ningqiang Gong, Xucong Teng, Jinghong Li, et al.
ACS Applied Materials & Interfaces (2018) Vol. 11, Iss. 1, pp. 37-42
Closed Access | Times Cited: 132

Non-coding RNA in bladder cancer
Yi Li, Gang Li, Xiangyang Guo, et al.
Cancer Letters (2020) Vol. 485, pp. 38-44
Closed Access | Times Cited: 116

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells
Chengwu Zeng, Sichu Liu, Shuai Lü, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 115

Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA‐Binding Scaffold
Anita Donlic, Brittany S. Morgan, Jason L. Xu, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 40, pp. 13242-13247
Open Access | Times Cited: 102

MALAT1 long non-coding RNA and breast cancer
Gayatri Arun, David L. Spector
RNA Biology (2019) Vol. 16, Iss. 6, pp. 860-863
Open Access | Times Cited: 96

RNA methyltransferase METTL16: Targets and function
Emily Satterwhite, Kyle D. Mansfield
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 13, Iss. 2
Open Access | Times Cited: 93

Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer
Sorina Dinescu, Simona Ignat, Andreea Daniela Lazăr, et al.
Genes (2019) Vol. 10, Iss. 1, pp. 52-52
Open Access | Times Cited: 91

Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies
Subhasree Kumar, Edward A. Gonzalez, Pranela Rameshwar, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3657-3657
Open Access | Times Cited: 91

Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
Yuanliang Yan, Zhijie Xu, Xi Chen, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 89

Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway
Yijing Zhao, Lei Zhou, Hui Li, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 264-276
Open Access | Times Cited: 87

MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Kung-Chi Chang, Sarah D. Diermeier, Allen T. Yu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 82

Page 1 - Next Page

Scroll to top